As of October 12, 2005 Mr. Richard Abbe Iroquois Master Fund Ltd.Vaso Active Pharmaceuticals Inc • November 14th, 2005 • Pharmaceutical preparations
STANDSTILL AGREEMENT WITH RESPECT TO CONVERSION RIGHTS, AS AMENDEDStandstill Agreement • November 14th, 2005 • Vaso Active Pharmaceuticals Inc • Pharmaceutical preparations
BioChemics, Inc., a Delaware corporation (“BioChemics”), is the holder of 4,500,000 shares of Class B Common Stock, par value $0.0001 per share (the “Class B Common Stock”), of Vaso Active Pharmaceuticals, Inc., a Delaware corporation (the “Company”), which amount constitutes all outstanding shares of Class B Common Stock. As of the date of this agreement, BioChemics holds approximately a 45% economic interest in the Company.
As of October 12, 2005 Smithfield Fiduciary LLC c/o Highbridge Capital Management, LLCVaso Active Pharmaceuticals Inc • November 14th, 2005 • Pharmaceutical preparations
